The University of New South Wales
unsw.edu.auLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
66
Active
5
Phase 3
7
Total enrollment
8,954
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| 0.1% Ciclosporin A eye drops | — | — | — | — | — | 1 | |
| Mineral oils eye drops | — | — | — | — | — | 1 |
Next readouts
- 2026-12-30
Top conditions
- Depression9
- Major Depression8
- Bipolar Disorder4
- Major Depressive Disorder3
- Bipolar Depression2
- Ankle Fractures2
- Osteoarthritis2
- Dry Eye Syndromes2
Frequently asked questions about The University of New South Wales
- How many clinical trials does The University of New South Wales have on ClinicalTrials.gov?
- The University of New South Wales is listed as the lead sponsor on 66 clinical trials in ClinicalTrials.gov, 5 of which are currently active (recruiting, enrolling, or ongoing).
- How many of The University of New South Wales's trials are in Phase 3?
- 7 of The University of New South Wales's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does The University of New South Wales focus on?
- The University of New South Wales's most-studied conditions on ClinicalTrials.gov are Depression, Major Depression, Bipolar Disorder, Major Depressive Disorder, Bipolar Depression.
- When are The University of New South Wales's next clinical trial readouts?
- The University of New South Wales has 1 upcoming primary-completion readout tracked here; the soonest is “The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Eye Surface Immune Cells in Dry Eyes”, expected around 2026-12-30.